Publications of M. Paez-Pereda
All genres
Journal Article (48)
41.
Journal Article
18 (14), doi:10.1096/fj.04-2138fje (2004)
Sonic hedgehog regulates CRH signal transduction in the adult pituitary. FASEB Journal 42.
Journal Article
130B (1), p. 122 - 122 (2004)
Identification and characterisation of a gene predisposing to both bipolar and unipolar afective disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 43.
Journal Article
563 (1-3), pp. 229 - 233 (2004)
Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. FEBS Letters 44.
Journal Article
4, pp. 335 - 342 (2004)
New perspectives in the treatment of Cushing`s Syndrome. Current Drug Targets - Immune, Endocrine & Metabolic Disorders 45.
Journal Article
207 (1-2), pp. 13 - 20 (2003)
Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development. Molecular and Cellular Endocrinology 46.
Journal Article
108, pp. 1123 - 1131 (2001)
Retinoic acid prevents experimental Cushing syndrome. Journal of Clinical Investigation 47.
Journal Article
98, pp. 1409 - 1416 (1996)
Cytokines enhance target cell sensitivity to glucocorticoids. Journal of Clinixal Investigation 48.
Journal Article
136, pp. 5182 - 5188 (1995)
Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology Book Chapter (7)
49.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)
Cytokines and Genes in Pituitary Tumorigenesis: RSUME Role in Cell Biology. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, pp. 1 - 6 (Eds. 50.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). Karger, Basel (2010)
Novel Medical Therapies for Pituitary Tumors. In: Pituitary Today II: New Molecular, Physiological and Clinical Aspects, pp. 158 - 164 (Eds. 51.
Book Chapter
Intrapituitary Expression and Regulation of the gp130 Cytokine Interleukin-6 and Its Implication in Pituitary Physiology and Pathophysiology. In: Neuroimmunomodulation: from fundamental biology to therapy, pp. 89 - 97 (Ed. Savino, W.). Blackwell, Boston, Mass. (2009)
52.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)
Bone morphogenetic protein-4 control of pituitary pathophysiology. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, pp. 22 - 31 (Eds. 53.
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)
New aspects in the diagnosis and treatment of Cushing disease. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, pp. 169 - 178 (Eds. 54.
Book Chapter
Hormones of the pituitary. In: Handbook of Stress and the Brain. Part 1, pp. 67 - 77 (Eds. Steckler, T.; Kalin, N.H.; Reul, J.M.H.M.). Elsevier, Amsterdam (2005)
55.
Book Chapter
Growth Factors and Cytokine: Function and Molecular Regulation in Pituitary Adenomas. In: Molecular Pathology of the Pituitary, pp. 96 - 109 (Eds. Kontogeorgos, G.; Kovacs, K.). Karger, Basel (2004)
Meeting Abstract (1)
56.
Meeting Abstract
122 (3), P032. 57th Symposium of the German Society of Endocrinology, Dresden, March 19, 2014 - March 22, 2014. Johann Ambrosius Barth Verlag Medizinverlage Heidelberg GmbH, Stuttgart, Germany (2014)
C-terminal Hsp90 inhibitors restore glucocorticoid sensitivity in an experimental model for Cushing's disease. In EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES,